Kyle Rose
Stock Analyst at Canaccord Genuity
(4.18)
# 555
Out of 4,412 analysts
66
Total ratings
50.56%
Success rate
13.43%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Upgrades: Buy | $360 | $335.61 | +7.27% | 10 | Jan 31, 2024 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $50.55 | +40.46% | 5 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $55.26 | +28.48% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $17.14 | +28.35% | 7 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $3.24 | +208.64% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $12.44 | +76.85% | 1 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $124.34 | +20.64% | 9 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $12 → $9 | $0.27 | +3,233.33% | 3 | May 31, 2023 | |
| SIBN SI-BONE | Maintains: Buy | $24 → $27 | $14.57 | +85.31% | 2 | May 2, 2023 | |
| TELA TELA Bio | Reiterates: Buy | $15 | $4.45 | +237.08% | 1 | Mar 28, 2023 | |
| AXGN AxoGen | Reiterates: Buy | $15 | $6.63 | +126.24% | 3 | Mar 28, 2023 | |
| ICE Intercontinental Exchange | Maintains: Market Perform | $125 → $122 | $131.70 | -7.37% | 1 | Mar 1, 2023 | |
| KRMD KORU Medical Systems | Upgrades: Buy | $3 → $4 | $2.19 | +82.65% | 3 | Nov 10, 2022 | |
| BVS Bioventus | Downgrades: Hold | n/a | $3.98 | - | 2 | Nov 9, 2022 | |
| PODD Insulet | Maintains: Buy | $250 → $290 | $166.19 | +74.50% | 4 | Aug 5, 2022 | |
| FNA Paragon 28 | Maintains: Buy | $25 → $23 | $8.80 | +161.36% | 2 | Mar 9, 2022 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Hold | $165 → $125 | $119.35 | +4.73% | 4 | Feb 8, 2022 | |
| SNN Smith & Nephew | Maintains: Buy | n/a | $24.45 | - | 2 | Apr 30, 2021 |
Stryker
Jan 31, 2024
Upgrades: Buy
Price Target: $360
Current: $335.61
Upside: +7.27%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $50.55
Upside: +40.46%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $55.26
Upside: +28.48%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $17.14
Upside: +28.35%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $3.24
Upside: +208.64%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $12.44
Upside: +76.85%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $124.34
Upside: +20.64%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $12 → $9
Current: $0.27
Upside: +3,233.33%
SI-BONE
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $14.57
Upside: +85.31%
TELA Bio
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $4.45
Upside: +237.08%
AxoGen
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $6.63
Upside: +126.24%
Intercontinental Exchange
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $131.70
Upside: -7.37%
KORU Medical Systems
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $2.19
Upside: +82.65%
Bioventus
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $3.98
Upside: -
Insulet
Aug 5, 2022
Maintains: Buy
Price Target: $250 → $290
Current: $166.19
Upside: +74.50%
Paragon 28
Mar 9, 2022
Maintains: Buy
Price Target: $25 → $23
Current: $8.80
Upside: +161.36%
Zimmer Biomet Holdings
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $119.35
Upside: +4.73%
Smith & Nephew
Apr 30, 2021
Maintains: Buy
Price Target: n/a
Current: $24.45
Upside: -